JPS6140391B2 - - Google Patents
Info
- Publication number
- JPS6140391B2 JPS6140391B2 JP52019161A JP1916177A JPS6140391B2 JP S6140391 B2 JPS6140391 B2 JP S6140391B2 JP 52019161 A JP52019161 A JP 52019161A JP 1916177 A JP1916177 A JP 1916177A JP S6140391 B2 JPS6140391 B2 JP S6140391B2
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- bacterial
- powder
- drying
- dispersion medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Dairy Products (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は、コーンステープリカーを含有する分
散媒を用いることにより乾燥時、および保存中に
菌の死滅が少ない菌粉末を製造する方法に関す
る。
乳酸菌又はビフイドバクテリウム菌の菌粉末を
製造する場合培養液から分離して集菌した菌体
を、一旦、保護物質の水溶液(分散媒)に懸濁さ
せてから乾燥粉末化するのが一般的であり用いる
保護物質が菌の乾燥歩留り、保存性に大きな影響
を及ぼすことが知られている。
乳酸菌又はビフイドバクテリウム菌の菌粉末の
製造に用いられる保護物質には、グルコース、乳
糖、蔗糖、リンゴ酸、アスパラギン酸、リジン、
グルタミン酸、アルギニン、ソルビトールキシリ
トールなどに代表される糖類、ポリアルコール
類、アミノ酸類、有機酸類のように水素結合が強
く、6炭素環にOH基やNH2基が配置されるなど
の一定の分子形とサイズを有する低分子化合物、
アルブミン、ゼラチン、可溶性澱粉、アルギン
酸、酵母エキス、カルボキシメチルセルロース、
血清、脱脂粉乳に代表される高分子化合物および
天然の混合物がある。これ等の保護物質は、低分
子化合物は水素結合が強いので、乾燥時、水に代
つて菌の細胞成分を安定にし、高分子化合物又は
天然の混合物は、細胞の表面を覆つて細胞膜の損
傷を防止することによるものと考えられており、
更に低分子化合物と、高分子化合物又は天然の混
合物を併用すれば、菌の死滅をより少なくするこ
とができる。
しかしながら、これ等の物質は、一般に高価な
ものであるため、これを大量に使用することは実
用的でなく、又、長期間、多数の生菌を含む菌粉
末は得られていないのが現状である。
本発明者等は乳酸菌又はビフイドバクテリウム
菌の菌粉末の製造に用いる菌の保護物質につい
て、種々検討した結果、コーンステープリカーに
優れた保護作用があることをつきとめたことによ
り本発明に達した。
以下試験例を示して本発明を詳述する。
試験例 1
乳酸菌として、ラクトバチルスアシドフイルス
()、同ヘルベテイクス()、同ブルガリクス
()、同プランタルム()、同カゼイ()、同
ブレビス()、及びビフイドバクテリウム菌と
して、ビフイドバクテリウムビフイダム()、
同ロンガム()を各々ILS倍地1に37℃20時
間培養し、培養後、直ちに冷凍遠心分離機で培養
液より菌体を分離、集菌した。得られた菌体を等
量2分し、
(イ) 脱脂粉乳10.0%(重量%以下同じ)、グルタ
ミン酸ソーダー1.0%、ビタミンC0.5%、PH7.0
の分散媒30mlに均一に懸濁させて、−30℃真空
度50μHgで8時間乾燥して粉末化した。(対
照)
(ロ) コーンステープリカー2.0%、脱脂粉乳10
%、グルタミン酸ソーダー1.0%、ビタミン
C0.5%、PH7.0の分散媒30mlに均一に懸濁させ
て、前記と同じ条件で乾燥粉末化した。(本発
明)
上記の二方法で得られた乾燥直後の菌の生残率
は第1表のとおりである。乳酸菌、ビフイドバク
テリウム菌は、乾燥させることによつて死滅する
傾向にあるが、コーンステープリカーを用いた本
発明の方法は、従来の最も実用的な分散媒を用い
た対照法に比較して、菌種によつて多少の差異は
あるが、いずれも菌の生残率は高く、死滅が少な
い。
The present invention relates to a method for producing a bacterial powder in which bacteria are less likely to die during drying and storage by using a dispersion medium containing corn staple liquor. When manufacturing bacterial powder of lactic acid bacteria or Bifidobacterium bacteria, it is common practice to first suspend the bacterial cells collected from the culture medium in an aqueous solution (dispersion medium) of a protective substance and then dry and powder them. It is known that the protective substances used have a large effect on the drying yield and storage stability of bacteria. Protective substances used in the production of lactic acid bacteria or Bifidobacterium powder include glucose, lactose, sucrose, malic acid, aspartic acid, lysine,
Saccharides such as glutamic acid, arginine, sorbitol xylitol, etc., polyalcohols, amino acids, organic acids, etc. have strong hydrogen bonds, and have certain molecular shapes such as OH groups and NH 2 groups arranged on the 6-carbon ring. A low-molecular compound with a size of
Albumin, gelatin, soluble starch, alginic acid, yeast extract, carboxymethylcellulose,
These include serum, high-molecular compounds such as skim milk powder, and natural mixtures. These protective substances are low-molecular compounds that have strong hydrogen bonds, so they stabilize bacterial cell components instead of water during drying, and high-molecular compounds or natural mixtures cover the surface of cells and prevent damage to cell membranes. It is thought that this is due to the prevention of
Furthermore, if a low-molecular compound and a high-molecular compound or a natural mixture are used together, the killing of bacteria can be further reduced. However, since these substances are generally expensive, it is not practical to use them in large quantities, and it is currently not possible to obtain bacterial powder containing a large number of viable bacteria for a long period of time. It is. The present inventors conducted various studies on bacterial protective substances used in the production of lactic acid bacteria or Bifidobacterium bacterial powder, and as a result, they discovered that corn staple liquor had an excellent protective effect, and thus arrived at the present invention. did. The present invention will be described in detail below with reference to test examples. Test Example 1 Lactobacillus acidophilus (), Lactobacillus acidophilus (), Lactobacillus acidophilus (), Lactobacillus bulgaricus (), Lactobacillus casei (), Lactobacillus casei (), Lactobacillus brevis () were used as lactic acid bacteria, and Bifidobacterium was used as Bifidobacterium. Bacterium bifidum (),
The same Longum () was cultured in ILS medium 1 at 37°C for 20 hours, and immediately after culturing, bacterial cells were separated from the culture solution using a refrigerated centrifuge and collected. Divide the obtained bacterial cells into two equal parts, and add (a) skim milk powder 10.0% (same weight %), sodium glutamate 1.0%, vitamin C 0.5%, pH 7.0.
The mixture was homogeneously suspended in 30 ml of a dispersion medium and dried at -30° C. under a vacuum of 50 μHg for 8 hours to form a powder. (Control) (b) Corn staple liquor 2.0%, skim milk powder 10
%, Sodium Glutamate 1.0%, Vitamins
It was uniformly suspended in 30 ml of a dispersion medium containing 0.5% C and PH 7.0, and dried and powdered under the same conditions as above. (Present Invention) The survival rates of bacteria immediately after drying obtained by the above two methods are shown in Table 1. Lactic acid bacteria and Bifidobacterium tend to be killed by drying, but the method of the present invention using corn staple liquor has a tendency to be killed by drying, compared to the control method using conventional and most practical dispersion media. Although there are some differences depending on the type of bacteria, the survival rate of all types of bacteria is high and mortality is low.
【表】【table】
【表】
試験例 2
試験例1(イ)、(ロ)の方法で得られた乾燥物を乾燥
澱粉中に各々生菌数が1.0×109/gになるように
混合した後、密封容器に入れて乳酸菌37℃、ビフ
イドバクテリウム菌30℃で保存した。保存中の生
菌数を測定した結果を第2表に示す。乳酸菌、ビ
フイドバクテリウム菌の生菌数は、保存が長くな
るほど減少する傾向にあるが、コーンステープリ
カーを用いた本発明の方法の保存6ケ月目では、
菌種によつて差異はあるが、全菌種生菌数107/
g以上が維持されており、保存12ケ月目になると
対照法に比較して10〜1000倍の生菌が残存する。[Table] Test Example 2 The dried products obtained by the methods of Test Example 1 (a) and (b) were mixed in dry starch so that the number of viable bacteria was 1.0 x 10 9 /g, and then placed in a sealed container. The bacteria were stored at 37°C for lactic acid bacteria and at 30°C for bifidobacterium. Table 2 shows the results of measuring the number of viable bacteria during storage. The number of viable bacteria of lactic acid bacteria and Bifidobacterium tends to decrease as storage length increases, but after 6 months of storage using the method of the present invention using corn staple liquor,
Although there are differences depending on the bacterial species, the number of viable bacteria for all bacterial species is 10 7 /
After 12 months of storage, 10 to 1000 times more viable bacteria remain than in the control method.
【表】【table】
【表】
以上のようにコーンステープリカーを菌粉末製
造用の分散媒に添加使用すれば、乾燥時および保
存中の菌の死滅防止に優れた効果を発揮する。
本発明の方法を実施するにあたり、菌の培養は
菌粉末の製造に好適な菌種と培地を用いて、37℃
で30時間程度とし、最高菌数に到達した頃、培養
液から菌体を分離集菌すればよい。分散媒に添加
使用するコーンステープリカーは、分散媒の1%
以上、好ましくは2〜3%使用し、凍結乾燥する
場合、7%を越えると乾燥時間が長くなる傾向が
ある。菌体は、分散媒に均一に懸濁させてから凍
結乾燥粉又は噴霧乾燥のいずれかの方法で乾燥粉
末化するが、得られた菌粉末の150〜250倍重量の
乾燥澱粉などと混合してそのまま保存使用する
か、又は打錠機で打錠して錠剤化してから保存、
使用してもよい。
因みに本発明の方法を実施すれば、乾燥時およ
び保存中の菌の死滅をより少なくできるから、多
数の生菌を含有する長期保存に適した菌粉末を得
ることができる。
以下実施例を示す。
実施例 1
ラクトバチルスアシドフイルスのスタータを
ILS培地1に接種して37℃20時間培養した。
後、培養液を冷凍遠心分離機に導びいて10000g
10分間5℃で培養液から菌体を分離、集菌した。
得られた菌体をコーンステープリカー2.0%、脱
脂乳粉10.0%、グルタミン酸ソーダー1.0%、ビ
タミンC1.0%、PH7.0の分散媒30mlに均一に懸濁
してから、凍結温度−30℃、乾燥棚温30℃、真空
度50μHgの条件で乾燥粉末化した。得られた乾
燥物は5.1g、庶生菌数2.9×1011/g生残率96%
であつた。この乾燥物を200倍量の乾燥澱粉中に
混合し、密封容器に入れて1ケ年間保存した。
保存後の生菌数は2.0×105/gであつた。
実施例 2
ビフイドバクテリウムビフイダムのスターター
をILS培地1に接種して37℃20時間培養した。
後、培養液を実施例1に同じ方法で菌体を分離、
集菌した。得られた菌体をコーンステープリカー
3.0%、脱脂粉乳のプロテアーゼ分解物5.0%、蔗
糖5.0%、アルギニン1.0%、PH7.0の分散媒30mlに
均一に懸濁してから、実施例1に同じ方法で乾燥
粉末化した。得られた乾燥物は5.2g、生菌数1.0
×1011/g、生残率90%であつた。この乾燥物を
200倍量の乾燥澱粉中に混合させた後(生菌数1.8
×109/g)、打錠機で打錠して錠剤化し、密封容
器に入れて1ケ年間保存した。
保存後の生菌数は2.5×107/gであつた。[Table] As described above, when corn staple liquor is added to a dispersion medium for producing bacterial powder, it exhibits an excellent effect in preventing killing of bacteria during drying and storage. In carrying out the method of the present invention, bacteria are cultured at 37°C using a suitable bacterial strain and medium for producing bacterial powder.
After about 30 hours, when the maximum number of bacteria is reached, the bacteria can be isolated and collected from the culture solution. Corn staple liquor added to the dispersion medium is 1% of the dispersion medium.
As mentioned above, preferably 2 to 3% is used, and when freeze-drying, if it exceeds 7%, the drying time tends to be longer. The bacterial cells are homogeneously suspended in a dispersion medium and then turned into a dry powder using either freeze-dried powder or spray drying. Store and use as is, or press into tablets with a tablet machine and store.
May be used. Incidentally, if the method of the present invention is carried out, the death of bacteria during drying and storage can be reduced, so that a bacterial powder containing a large number of viable bacteria and suitable for long-term storage can be obtained. Examples are shown below. Example 1 Lactobacillus acidophilus starter
It was inoculated into ILS medium 1 and cultured at 37°C for 20 hours.
After that, the culture solution was introduced into a refrigerated centrifuge and centrifuged at 10,000 g.
Bacterial cells were separated from the culture solution at 5° C. for 10 minutes and collected.
The obtained bacterial cells were uniformly suspended in 30 ml of a dispersion medium containing 2.0% corn staple liquor, 10.0% skim milk powder, 1.0% sodium glutamate, 1.0% vitamin C, and pH 7.0, and then frozen at -30°C. It was dried and powdered under the conditions of a drying shelf temperature of 30°C and a vacuum degree of 50 μHg. The obtained dry matter was 5.1g, and the average number of viable bacteria was 2.9×10 11 /g, with a survival rate of 96%.
It was hot. This dried product was mixed with 200 times the amount of dried starch, and stored in a sealed container for one year. The number of viable bacteria after storage was 2.0×10 5 /g. Example 2 A starter of Bifidobacterium bifidum was inoculated into ILS medium 1 and cultured at 37°C for 20 hours.
After that, isolate the bacterial cells using the culture solution in the same manner as in Example 1.
Bacteria were collected. The obtained bacterial cells are mixed with cornstaple liquor.
The suspension was homogeneously suspended in 30 ml of a dispersion medium containing 3.0% protease decomposition product of skim milk powder, 5.0% sucrose, 1.0% arginine, and pH 7.0, and then dried and powdered in the same manner as in Example 1. The obtained dry matter was 5.2g, and the number of viable bacteria was 1.0.
×10 11 /g, survival rate was 90%. This dried product
After mixing in 200 times the amount of dry starch (viable bacteria count 1.8)
×10 9 /g) was compressed into tablets using a tablet machine, and stored in a sealed container for one year. The number of viable bacteria after storage was 2.5×10 7 /g.
Claims (1)
より該菌体を集菌した後、該菌体をコーンステー
プリカーを含有する分散媒に懸濁してから乾燥粉
末化することを特徴とする菌粉末の製造法。1. A bacterial powder characterized by culturing lactic acid bacteria or bifidobacteria, collecting the bacteria from the culture solution, suspending the bacteria in a dispersion medium containing corn staple liquor, and then drying and powdering the bacteria. manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1916177A JPS53104787A (en) | 1977-02-25 | 1977-02-25 | Production of powder of lactic acid producing bacteria or bifidobacterium germ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1916177A JPS53104787A (en) | 1977-02-25 | 1977-02-25 | Production of powder of lactic acid producing bacteria or bifidobacterium germ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS53104787A JPS53104787A (en) | 1978-09-12 |
JPS6140391B2 true JPS6140391B2 (en) | 1986-09-09 |
Family
ID=11991661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1916177A Granted JPS53104787A (en) | 1977-02-25 | 1977-02-25 | Production of powder of lactic acid producing bacteria or bifidobacterium germ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS53104787A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5732221A (en) * | 1980-08-05 | 1982-02-20 | Morinaga & Co Ltd | Preparation of tablet confection containing lactobacillus bifidus |
JPH07106143B2 (en) * | 1987-04-09 | 1995-11-15 | 株式会社ヤクルト本社 | Method for producing powder containing Bifidobacterium |
US4991045A (en) * | 1987-12-21 | 1991-02-05 | Hutchinson Technology, Inc. | Suspension assembly |
JP2005124432A (en) * | 2003-10-22 | 2005-05-19 | Shuichi Shiomi | Health food |
JP2016193894A (en) * | 2015-04-01 | 2016-11-17 | 京都薬品工業株式会社 | Viable cell-containing preparation |
-
1977
- 1977-02-25 JP JP1916177A patent/JPS53104787A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS53104787A (en) | 1978-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2730646B1 (en) | Drying lactic acid bacteria and new compositions | |
KR101604633B1 (en) | Medium composition for culturing lactic acid bacteria and producing method of powder of lactic acid bacteria using the same | |
CN113652359B (en) | Lactic acid bacteria freeze-dried powder, preparation method and freeze-dried protective agent thereof | |
JP2002513559A (en) | Dried microbial culture and method for producing the same | |
CN107868769A (en) | A kind of high activity bifidobacteria freeze-dried vaccine powder producing method and application | |
KR102290654B1 (en) | Cryoprotectant compositions and lactic acid bacteria preparations comprising the same | |
CN108271382A (en) | Microorganism dries the manufacturing method of thalline | |
CN113005040B (en) | Bifidobacterium lactis freeze-drying protective agent and application method thereof | |
KR20160051902A (en) | Lactic acid bacteria compositions comprising alginate beads that lactic acid bacteria embedded therein and soy powder as a cryoprotectant with enhanced survival rate of the lactic acid bacteria, methods of preparing the same, and use thereof | |
JP7444949B2 (en) | Medium for lactic acid bacteria | |
KR101951893B1 (en) | Method for producing high concentration of probiotic active Lactobacillus paracasei SRCM102343 strain derived from traditional fermented food | |
JPS6140391B2 (en) | ||
KR101425712B1 (en) | Method of tynadallized Lactobacillus acidophilus | |
EP1867713B1 (en) | Method of improving storage stability of dried microorganisms | |
AU2019369917A1 (en) | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria | |
Urbański et al. | Influence of whey on viability of Lactobacillus gasseri during freeze-drying process | |
JP2020137456A (en) | Culture medium for culture of lactic acid bacteria | |
KR102558052B1 (en) | Probiotics Powder Composition Using Microalgae Extracts and Preparation method thereof | |
TWI810246B (en) | Production method of dried microbial cells with high survivability | |
KR102064102B1 (en) | Probiotics Powder Composition Using Biopolymer and Preparation method thereof | |
KR20180091603A (en) | Probiotics Powder Composition Using Biopolymer and Preparation method thereof | |
JPH0416145B2 (en) | ||
RU2067114C1 (en) | Method of dry probiotic preparation preparing | |
JP2012056921A (en) | Probiotic preparation | |
JPH07106143B2 (en) | Method for producing powder containing Bifidobacterium |